3-FLUORO-2-(4-MORPHOLINO)PYRIDINE-4-BORONIC ACID PINACOL ESTER, 97.0%, 1g

(S)-ETHYL 4-BROMO-2-METHYL-2-(METHYLSULFONYL)BUTANOATE, 95.0%, 2g

tert-Butyl (2-(2-aminoethoxy)ethyl)(methyl)carbamate, 95%, 500mg

Platinschwarz 10-20 m?/g 5 g

9,10-Diphenylanthracene (purified by sublimation)>99.0%(GC)1g

N-CARBAMOYL-2-METHYL BENZENE SULFONAMIDE, 95.0%, 1g

METHYL 2-(1-AMINOCYCLOBUTYL)ACETATE, 95.0%, 250mg

1-(6-(Dimethylamino)naphthalen-2-yl)propan-1-one, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-1701 MS, L 60 m, Ø-Innen 0,32 mm, Filmd. 0,50 µm, 1 Stück

N,N-DIETHYL-9H-PURIN-2-AMINE, 95.0%, 500mg

(S)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione, 98%, 10g

5-Chloro-4-nitro-1,3-dimethylpyrazole, 97.0%, 5g

(R)-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methanamine, 95.0%, 1g